Engagement in Lifestyle Activities is Associated with Increased Alzheimer’s Disease-Associated Cortical Thickness and Cognitive Performance in Older Adults

The aim of this study was to examine the association between lifestyle activities, including physical, cognitive, and social activities, and Alzheimer’s disease (AD) signature cortical thickness, as well as to examine the mediating role of AD signature cortical thickness in lifestyle activities and cognitive function in community-dwelling healthy older adults. Participants were 1026 older adults who met the study inclusion criteria. The physical, cognitive, and social activities of daily life were assessed using a self-reporting questionnaire. AD signature cortical thickness was determined using FreeSurfer software. Cognitive function was evaluated using the National Center for Geriatrics and Gerontology-Functional Assessment Tool. Path analysis (based on structural equation modeling (SEM)) of cognitive activities indicated that the direct path from cognitive activities to cognitive function was significant (p < 0.001), as was the direct path from AD signature cortical thickness to cognitive function (p < 0.001). Physical (p < 0.05) or social activities (p < 0.05) had a direct effect on cognitive function. However, AD signature cortical thickness did not mediate the relationship between physical or social activities and cognitive function. Our findings suggest that higher levels of cognitive activities later in life have a significant and positive direct effect on cognitive function. Additionally, AD signature cortical thickness significantly mediates the relationship between cognitive activities and cognitive function.

Download Full-text

Evidence of Mediation by Depressive Symptoms in the Association Between Frailty and Cognitive Decline in Older Adults

Innovation in Aging ◽

10.1093/geroni/igaa057.541 ◽

2020 ◽

Vol 4 (Supplement_1) ◽

pp. 167-167

Author(s):

Nicholas Resciniti ◽

Matthew Lohman ◽

Anwar Merchant

Keyword(s):

Older Adults ◽

Depressive Symptoms ◽

Cognitive Function ◽

Cognitive Decline ◽

Direct Effect ◽

Community Dwelling ◽

Frailty Phenotype ◽

Frailty Status ◽

Low Weight ◽

The Relationship

Abstract Frailty and pre-frailty have been shown to predict cognitive decline in older adults; however, knowledge about mediating pathways in this association is lacking. This study aims to assess if depressive symptoms mediate the relationship between frailty and cognitive function. Frailty status, cognitive function scores, and depressive symptoms were measured in 4,672 community-dwelling US adults ≥65 and older from the Health and Retirement Study from 2006-2010. Fried’s frailty phenotype criteria (weakness, slowness, physical inactivity, low weight, and exhaustion) were used to categorize individuals as frail (3-5 criteria), pre-frail (1-2 criteria) and robust (0 criteria). Memory recall and global mental status (from 0-35) was used to determine cognitive function. The CES-D was used to assess depressive symptoms. A causal mediation analysis was performed to estimate the direct effect (DE), the direct effect (DE), and the indirect effect (IE). Both frailty (TE: β=-1.22; 95% CI: -1.75, -0.68) and pre-frailty (TE: β=-0.52; 95% CI: -0.86, -0.18) were found to be associated with lower cognitive scores, after adjusting for confounders. There was significant but small IE between frailty status and declining cognitive scores mediated by depressive symptoms [frailty: β=-0.09 (95% CI: -0.14, -0.03); pre-frailty: β = -0.03 (95% CI: -0.06, -0.01). Additionally, the DE was significant for frailty (β=-1.13; 95% CI: -1.67, -0.59) and pre-frailty (β=-0.49 95% CI: -0.82, -0.15). This study provides evidence that depressive symptoms may mediate the association between frailty and cognitive decline. The results suggest possible intervenable pathways for preventing or delaying cognitive decline.

Download Full-text

Effects of Participation in Social Activities on Cognitive Function Among Middle-Aged and Older Adults in Korea

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph15102315 ◽

2018 ◽

Vol 15 (10) ◽

pp. 2315 ◽

Cited By ~ 3

Author(s):

Jongnam Hwang ◽

Sangmin Park ◽

Sujin Kim

Keyword(s):

Older Adults ◽

Cognitive Function ◽

Cognitive Decline ◽

Social Connectedness ◽

Social Activity ◽

Later Life ◽

Well Being ◽

Social Activities ◽

The Social ◽

Gender Groups

Cognitive function is a critical health issue in later life, the decline of which disrupts well-being and daily life function. Cognitive decline in older ages can also be understood in the context of the social environment such as social connectedness and engagement in personal life. This study aimed to examine: (1) whether participation in social activities contributes to preventing cognitive decline, and (2) what type of social activities are beneficial to maintaining cognitive function. Data from the Korean Longitudinal Study of Aging (KLOSA) 2006–2014, a longitudinal survey of the household-dwelling population aged 45 and older in Korea were used. The results revealed that Mini-Mental State Examination (MMSE) scores decreased with increasing age, at a rate of approximately 0.18 units across all age-gender groups, and the decrease was steeper for adults aged 65 and over. Participation in social gatherings was likely to delay the decline in cognitive function after the age of 65. In a gender-stratified model, social activity may not have an impact on the decline of cognitive function for men, whereas participation in social gatherings was negatively related to the decline of MMSE scores in women. This study suggests the need for a gender-stratified policy for preventing the decline of cognitive function while promoting engagement in social activities in Korean older adults.

Download Full-text

Abstract T P160: Influence of Polyunsaturated Fatty Acids on Cognition in Elderly Alzheimer's Disease Patients

Stroke ◽

10.1161/str.46.suppl_1.tp160 ◽

2015 ◽

Vol 46 (suppl_1) ◽

Author(s):

Takashi Yamazaki ◽

Ken Nagata ◽

Daiki Takano ◽

Tetsuya Maeda

Keyword(s):

Alzheimer’S Disease ◽

Blood Pressure ◽

Alzheimer's Disease ◽

Cognitive Function ◽

Mmse Score ◽

Characteristic Curve ◽

Follow Up Study ◽

Cognitive Stability ◽

The Relationship

Background: Many genes and environmental factors linked to Alzheimer’s disease (AD) risk affect lipid metabolism or the cardiovascular system, strongly implicating cerebrovascular and metabolic dysfunction in AD pathogenesis. Although some PUFAs may improve cognitive function in aging individuals, it is still unclear how different PUFAs influence AD neuropathology and cognitive function. Objective: To examine the influence of polyunsaturated fatty acid (PUFA) metabolism on AD-associated cognitive decline, we investigated the relationship between serum PUFA profile and neuropsychological test performance. Methods: Cognitive functioning in patients with probable AD (n = 174, mean age 77.6 years) was examined using the Mini-Mental State Exam (MMSE) and clock drawing test (CDT). Serum samples were obtained for PUFA profile, including the eicosapentaenoic acid/arachidonic acid (EPA/AA) ratio, and measurement of brain natriuretic peptide (BNP) concentration. In the follow-up study, 47 subjects repeated MMSE and CDT after 1 year, According to the second MMSE score, the subjects were divided into the following 2 groups: those with unchanged or improved MMSE score and those with lower MMSE score. A receiver operating characteristic curve was used to evaluate the relationship between the EPA/AA ratio and 1-year cognitive stability. Results: In the cross-sectional study, total MMSE score correlated positively with the EPA/AA ratio and systolic blood pressure (SBP), and negatively with age and diastolic blood pressure (DBP) (p < 0.05). In the follow-up study, the MMSE score was lower than baseline in 20 subjects, whereas it was improved or unchanged in 29 patients. The EPA/AA ratio in the stable group was significantly greater than that in the deteriorating group, suggesting an association between higher EPA/AA ratio and cognitive stability over 1 year. The EPA/AA ratio predicted stability of cognitive performance with a sensitivity of 66% and specificity of 70% (odds ratio = 4.43) when the cut-off was 0.67. Conclusion: Our results suggest that serum EPA concentration strongly influences cognitive performances in AD patients. The EPA/AA ratio was a sensitive indicator of cognitive stability in this patient group.

Download Full-text